Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Moly Rani, Ashutosh Nath & Ajoy Kumer. (2023) In-silico investigations on the anticancer activity of selected 2-aryloxazoline derivatives against breast cancer. Journal of Biomolecular Structure and Dynamics 41:17, pages 8392-8401.
Read now
Read now
M Mahbub Hasan, AHM Nurun Nabi & Tahirah Yasmin. (2023) Comprehensive analysis predicting effects of deleterious SNPs of human progesterone receptor gene on its structure and functions: a computational approach. Journal of Biomolecular Structure and Dynamics 41:16, pages 8002-8017.
Read now
Read now
Jerome H. Check & Diane L. Check. (2023) The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years. Expert Review of Endocrinology & Metabolism 18:1, pages 5-18.
Read now
Read now
Akshita Gupta & Yatender Kumar. (2020) Bispecific antibodies: a novel approach for targeting prominent biomarkers. Human Vaccines & Immunotherapeutics 16:11, pages 2831-2839.
Read now
Read now
Maria V. Deligiorgi, Mihalis I. Panayiotidis & Dimitrios T. Trafalis. (2020) Repurposing denosumab in breast cancer beyond prevention of skeletal related events: Could nonclinical data be translated into clinical practice?. Expert Review of Clinical Pharmacology 13:11, pages 1235-1252.
Read now
Read now
Jerome H Check. (2017) The role of progesterone and the progesterone receptor in cancer. Expert Review of Endocrinology & Metabolism 12:3, pages 187-197.
Read now
Read now
Jerome H Check & Rachael Cohen. (2013) The role of progesterone and the progesterone receptor in human reproduction and cancer. Expert Review of Endocrinology & Metabolism 8:5, pages 469-484.
Read now
Read now
Lev M Berstein. (2011) Endocrinology of breast cancer: results, tasks and hopes. Expert Review of Endocrinology & Metabolism 6:3, pages 293-297.
Read now
Read now
Articles from other publishers (77)
Maria D. Hurtado, Elif Tama, Stacey D’Andre & Chrisandra L. Shufelt. (2024) The relation between excess adiposity and breast cancer in women: Clinical implications and management. Critical Reviews in Oncology/Hematology 193, pages 104213.
Crossref
Crossref
Fazileh Esmaeili, Mohsen Farhadpour, Mahdi Abbas-Mohammadi, Mostafa Alilou, Dina Morshedi, Esmaeil Ebrahimie & Tahmineh Lohrasebi. (2023) Appraisals on the anticancer properties of Mentha species using bioassays and docking studies. Industrial Crops and Products 203, pages 117128.
Crossref
Crossref
Hai-long Chen, Feng-bo Huang, Qiang Chen & Yong-chuan Deng. (2023) Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers. BMC Cancer 23:1.
Crossref
Crossref
Misung Yi, Tingting Zhan, Amy R. Peck, Jeffrey A. Hooke, Albert J. Kovatich, Craig D. Shriver, Hai Hu, Yunguang Sun, Hallgeir Rui & Inna Chervoneva. (2023) Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data. BMC Bioinformatics 24:1.
Crossref
Crossref
Shweta Satpathi, Sagar S Gaurkar, Ashwini Potdukhe & Mayur B Wanjari. (2023) Unveiling the Role of Hormonal Imbalance in Breast Cancer Development: A Comprehensive Review. Cureus.
Crossref
Crossref
Wen Lai, Jianquan Chen, Tianming Wang & Qiaoling Liu. (2023) Crosstalk between ferroptosis and steroid hormone signaling in gynecologic cancers. Frontiers in Molecular Biosciences 10.
Crossref
Crossref
Faten Shehadeh-Tout, Heloisa H. Milioli, Suraya Roslan, Patric J. Jansson, Mahendiran Dharmasivam, Dinny Graham, Robin Anderson, Tharushi Wijesinghe, Mahan Gholam Azad, Des R. Richardson & Zaklina Kovacevic. (2023) Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer. Pharmacological Research 193, pages 106806.
Crossref
Crossref
Jainey P. JamesPramatha PramathaMariyam JouharaZakiya Fathima CRupal Ria D’Souza. (2023) Green Synthesis, Multitargeted Molecular Docking and ADMET Studies of Chalcones Based Scaffold as Anti-Breast Cancer Agents. Research Journal of Pharmacy and Technology, pages 2215-2222.
Crossref
Crossref
Özge Tanişman, Fatma Tuba Kiziltepe, Çiğdem Yildirim & Zehra Sumru Coşar. (2023) Prediction of prognostic factors in breast cancer: A noninvasive method utilizing histogram parameters derived from Adc maps. Heliyon 9:5, pages e16282.
Crossref
Crossref
Mohamed Ali, Michał Ciebiera, Somayeh Vafaei, Samar Alkhrait, Hsin-Yuan Chen, Yi-Fen Chiang, Ko-Chieh Huang, Stepan Feduniw, Shih-Min Hsia & Ayman Al-Hendy. (2023) Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics. Cells 12:8, pages 1117.
Crossref
Crossref
Carla Luís, João Dias, João Firmino-Machado, Rute Fernandes, Deolinda Pereira, Pilar Baylina, Rúben Fernandes & Raquel Soares. (2022) A retrospective study in tumour characteristics and clinical outcomes of overweight and obese women with breast cancer. Breast Cancer Research and Treatment 198:1, pages 89-101.
Crossref
Crossref
Lucas Porras, Faustine Gorse, Ndeye Khady Thiombane, Louis Gaboury & Sylvie Mader. (2022) CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3. Cancers 14:21, pages 5453.
Crossref
Crossref
Roman Beňačka, Daniela Szabóová, Zuzana Guľašová, Zdenka Hertelyová & Jozef Radoňák. (2022) Classic and New Markers in Diagnostics and Classification of Breast Cancer. Cancers 14:21, pages 5444.
Crossref
Crossref
Samik Hazra, Anindya Sundar Ray & Chowdhury Habibur Rahaman. (2022) Natural Phytocompounds from Common Indian Spices for Identification of Three Potential Inhibitors of Breast Cancer: A Molecular Modelling Approach. Molecules 27:19, pages 6590.
Crossref
Crossref
Christos Velesiotis, Marinos Kanellakis & Demitrios H. Vynios. (2022) Steviol glycosides affect functional properties and macromolecular expression of breast cancer cells. IUBMB Life 74:10, pages 1012-1028.
Crossref
Crossref
Jesse Yu, Qingxin Mu, Millie Fung, Xiaolin Xu, Linxi Zhu & Rodney J.Y. Ho. (2022) Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response. Pharmacology & Therapeutics 236, pages 108108.
Crossref
Crossref
Dursun Burak ÖZDEMİR, Ahmet KARAYİĞİT, Hayrettin DİZEN & Bülent ÜNAL. (2022) The role of red cell distribution width in predicting the prognosis of patients with breast cancer. Journal of Health Sciences and Medicine 5:4, pages 1170-1175.
Crossref
Crossref
Jerome H. Check & Diane L. Check. 2022. Drug Repurposing - Molecular Aspects and Therapeutic Applications. Drug Repurposing - Molecular Aspects and Therapeutic Applications.
Vikas Jha, Sakshi Devkar, Kunal Gharat, Sankalp Kasbe, Darpan Kaur Matharoo, Shalmali Pendse, Anjali Bhosale & Agraj Bhargava. (2022) Screening of Phytochemicals as Potential Inhibitors of Breast Cancer using Structure Based Multitargeted Molecular Docking Analysis. Phytomedicine Plus 2:2, pages 100227.
Crossref
Crossref
Namita Mahadik, Dwaipayan Bhattacharya, Akshaya Padmanabhan, Kalyani Sakhare, Kumar Pranav Narayan & Rajkumar Banerjee. (2021) Targeting steroid hormone receptors for anti‐cancer therapy—A review on small molecules and nanotherapeutic approaches. WIREs Nanomedicine and Nanobiotechnology 14:2.
Crossref
Crossref
E. M. Frantsiyants, V. A. Bandovkina, I. V. Kaplieva, E. I. Surikova, Yu. A. Pogorelova, N. D. Cheryarina, I. M. Kotieva, M. I. Morozova & A. I. Shikhlyarova. (2022) The impact of diabetes mellitus on levels of sex hormones and their receptors in tumor tissues in female rats with Guerin’s carcinoma. Research and Practical Medicine Journal 9:1, pages 23-32.
Crossref
Crossref
Yan Hong, Darlene Limback, Hanan S Elsarraj, Haleigh Harper, Haley Haines, Hayley Hansford, Michael Ricci, Carolyn Kaufman, Emily Wedlock, Mingchu Xu, Jianhua Zhang, Lisa May, Therese Cusick, Marc Inciardi, Mark Redick, Jason Gatewood, Onalisa Winblad, Allison Aripoli, Ashley Huppe, Christa Balanoff, Jamie L Wagner, Amanda L Amin, Kelsey E Larson, Lawrence Ricci, Ossama Tawfik, Hana Razek, Ruby O Meierotto, Rashna Madan, Andrew K Godwin, Jeffrey Thompson, Susan G Hilsenbeck, Andy Futreal, Alastair Thompson, E Shelley Hwang, Fang Fan & Fariba Behbod. (2021)
Mouse‐INtraDuctal
(
MIND
): an
in vivo
model for studying the underlying mechanisms of
DCIS
malignancy
. The Journal of Pathology 256:2, pages 186-201.
Crossref
Crossref
Adele Chimento, Arianna De Luca, Paola Avena, Francesca De Amicis, Ivan Casaburi, Rosa Sirianni & Vincenzo Pezzi. (2022) Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers. International Journal of Molecular Sciences 23:3, pages 1242.
Crossref
Crossref
Elaheh Tarighati, Hadi Keivan & Hojjat Mahani. (2022) A review of prognostic and predictive biomarkers in breast cancer. Clinical and Experimental Medicine.
Crossref
Crossref
Tatiana Kalinina, Vladislav Kononchuk, Lyubov Klyushova & Lyudmila Gulyaeva. (2022) Effects of Endocrine Disruptors o,p′-Dichlorodiphenyltrichloroethane, p,p′-Dichlorodiphenyltrichloroethane, and Endosulfan on the Expression of Estradiol-, Progesterone-, and Testosterone-Responsive MicroRNAs and Their Target Genes in MCF-7 Cells. Toxics 10:1, pages 25.
Crossref
Crossref
Aathmaja Anandhi Rangarajan. 2022. Genetics Fundamentals Notes. Genetics Fundamentals Notes
597
631
.
Bowei Zeng, Yiyang Lin, Yifeng Wang, Yang Chen, Jiuyang Dong, Xi Li & Yongbing Zhang. 2022. Medical Image Computing and Computer Assisted Intervention – MICCAI 2022. Medical Image Computing and Computer Assisted Intervention – MICCAI 2022
232
241
.
Charlène Thiebaut, Virginie Vlaeminck-Guillem, Olivier Trédan, Coralie Poulard & Muriel Le Romancer. (2021) Non-genomic signaling of steroid receptors in cancer. Molecular and Cellular Endocrinology 538, pages 111453.
Crossref
Crossref
Jerome H. Check & Diane L. Check. (2021) A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation. International Journal of Molecular Sciences 22:22, pages 12351.
Crossref
Crossref
Xiaofei Wang & Da Yang. (2021) The regulation of RNA metabolism in hormone signaling and breast cancer. Molecular and Cellular Endocrinology 529, pages 111221.
Crossref
Crossref
João Franco Machado, João D. G. Correia & Tânia S. Morais. (2021) Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer Cells. Molecules 26:11, pages 3153.
Crossref
Crossref
M G Davey, É J Ryan, P J Folan, N O’Halloran, M R Boland, M K Barry, K J Sweeney, C M Malone, R J McLaughlin, M J Kerin & A J Lowery. (2021) The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer. BJS Open 5:3.
Crossref
Crossref
Tamarra James-Todd, Lisa Connolly, Emma V. Preston, Marlee R. Quinn, Monika Plotan, Yuling Xie, Bharathi Gandi & Shruthi Mahalingaiah. (2021) Hormonal activity in commonly used Black hair care products: evaluating hormone disruption as a plausible contribution to health disparities. Journal of Exposure Science & Environmental Epidemiology 31:3, pages 476-486.
Crossref
Crossref
Martin Stortz, Diego M. Presman, Adali Pecci & Valeria Levi. (2021) Phasing the intranuclear organization of steroid hormone receptors. Biochemical Journal 478:2, pages 443-461.
Crossref
Crossref
Shinjini Ganguly, Divya Naik, Andrew Muskara & Omar Y Mian. (2021) The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability. Endocrinology 162:1.
Crossref
Crossref
Julianne M. Hall & Kenneth S. Korach. 2021. Endocrine-Disrupting Chemicals. Endocrine-Disrupting Chemicals
191
235
.
Gretel Mendoza-Almanza, Luis Burciaga-Hernández, Vilma Maldonado, Jorge Melendez-Zajgla & Jorge Olmos. (2020) Role of platelets and breast cancer stem cells in metastasis. World Journal of Stem Cells 12:11, pages 1237-1254.
Crossref
Crossref
Diego A. Pedroza, Venkatesh Rajamanickam, Ramadevi Subramani, Alejandra Bencomo, Adriana Galvez & Rajkumar Lakshmanaswamy. (2020) Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling. British Journal of Cancer 123:8, pages 1326-1335.
Crossref
Crossref
Michael R. Boland, Éanna J. Ryan, Timothy Nugent, Darina Gilroy, Michael E. Kelly, John Kennedy, Aoife Maguire, Dhafir Alazawi, Terence J. Boyle & Elizabeth M. Connolly. (2020) Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor‐positive breast cancer patients. Journal of Surgical Oncology 122:5, pages 861-868.
Crossref
Crossref
Kanchan Vishnoi, Navin Viswakarma, Ajay Rana & Basabi Rana. (2020) Transcription Factors in Cancer Development and Therapy. Cancers 12:8, pages 2296.
Crossref
Crossref
Jennifer R. Baker, Jennette A. Sakoff & Adam McCluskey. (2019) The aryl hydrocarbon receptor (AhR) as a breast cancer drug target. Medicinal Research Reviews 40:3, pages 972-1001.
Crossref
Crossref
Olga Ostrovsky, Israel Vlodavsky & Arnon Nagler. 2020. Heparanase. Heparanase
231
249
.
M R Boland, É J Ryan, E Dunne, T M Aherne, N R Bhatt & A J Lowery. (2020) Meta-analysis of the impact of progesterone receptor status on oncological outcomes in oestrogen receptor-positive breast cancer. British Journal of Surgery 107:1, pages 33-43.
Crossref
Crossref
Tiago Rodrigues, Bernardo P. de Almeida, Nuno L. Barbosa-Morais & Gonçalo J. L. Bernardes. (2019) Dissecting celastrol with machine learning to unveil dark pharmacology. Chemical Communications 55:45, pages 6369-6372.
Crossref
Crossref
Sanaz Salar Amoli, Khashayar Shahin, Sima Besharat, Amir Nader Emami Razavi & Hamidreza Joshaghani. (2019) Association of Tissue Selenium Level and p53 Expression in Breast Cancer. Medical Laboratory Journal 13:2, pages 30-33.
Crossref
Crossref
Afshan Fathima Nawas, Ragini Mistry, Shrinath Narayanan, Shayna Elizabeth Thomas‐Jardin, Janani Ramachandran, Jananisree Ravichandran, Ebin Neduvelil, Krisha Luangpanh & Nikki Ayanna Delk. (2018)
IL‐1 induces p62/SQSTM1 and autophagy in ERα
+
/PR
+
BCa cell lines concomitant with ERα and PR repression, conferring an ERα
−
/PR
−
BCa‐like phenotype
. Journal of Cellular Biochemistry 120:2, pages 1477-1491.
Crossref
Crossref
Manish Gore, Amita Puranik, Abhishek Indurkar, Bismita Sonowal, Padma V. Devarajan, Ratnesh Jain & Prajakta Dandekar. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
109
140
.
Meghan S Perkins, Renate Louw-du Toit & Donita Africander. (2018) Hormone therapy and breast cancer: emerging steroid receptor mechanisms. Journal of Molecular Endocrinology 61:4, pages R133-R160.
Crossref
Crossref
Meera Nair, Sardul Singh Sandhu & Anil Kumar Sharma. (2018) Cancer molecular markers: A guide to cancer detection and management. Seminars in Cancer Biology 52, pages 39-55.
Crossref
Crossref
Clara R. L. Oudenaarden, Robert A. H. van de Ven & Patrick W. B. Derksen. (2018) Re-inforcing the cell death army in the fight against breast cancer. Journal of Cell Science 131:16.
Crossref
Crossref
Sasagu Kurozumi, Hiroshi Matsumoto, Kenichi Inoue, Katsunori Tozuka, Yuji Hayashi, Masafumi Kurosumi, Tetsunari Oyama, Takaaki Fujii, Jun Horiguchi & Hiroyuki Kuwano. (2018) Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer. PLOS ONE 13:8, pages e0201846.
Crossref
Crossref
Cecilia J. Proietti, Mauro E. Cenciarini & Patricia V. Elizalde. (2018) Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions. Steroids 133, pages 75-81.
Crossref
Crossref
Sara Charmsaz, Éamon Hughes, Fiona T. Bane, Paul Tibbitts, Marie McIlroy, Christopher Byrne, Sinéad Cocchiglia, Jean McBryan, Bryan T. Hennessy, Róisín M. Dwyer, Michael J. Kerin, Arnold D. Hill & Leonie S. Young. (2017) S100β as a serum marker in endocrine resistant breast cancer. BMC Medicine 15:1.
Crossref
Crossref
Samra Khalid & Rumeza Hanif. (2017)
Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and
in-silico
expression analysis of CXCL12–CXCR4 associated biological regulatory network
. PeerJ 5, pages e3822.
Crossref
Crossref
Benjamin Ruprecht, Esther A. Zaal, Jana Zecha, Wei Wu, Celia R. Berkers, Bernhard Kuster & Simone Lemeer. (2017) Lapatinib Resistance in Breast Cancer Cells Is Accompanied by Phosphorylation-Mediated Reprogramming of Glycolysis. Cancer Research 77:8, pages 1842-1853.
Crossref
Crossref
Dominika Piasecka, Kamila Kitowska, Dominika Czaplinska, Kamil Mieczkowski, Magdalena Mieszkowska, Lukasz Turczyk, Andrzej C. Skladanowski, Anna J. Zaczek, Wojciech Biernat, Radzislaw Kordek, Hanna M. Romanska & Rafal Sadej. (2016) Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells. Oncotarget 7:52, pages 86011-86025.
Crossref
Crossref
Vahid Atashgaran, Joseph Wrin, Simon Charles Barry, Pallave Dasari & Wendy V. Ingman. (2016) Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk. Frontiers in Oncology 6.
Crossref
Crossref
Bin Wang, Huayong Jiang, Ning Ma & Yajie Wang. (2016) Phosphorylated-p38 mitogen-activated protein kinase expression is associated with clinical factors in invasive breast cancer. SpringerPlus 5:1.
Crossref
Crossref
Sanjit Agrawal, Lalit Banswal, Animesh Saha, Indu Arun, Soumitra Shankar Datta, Sanjoy Chatterjee & Rosina Ahmed. (2016) Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer – a Single Centre Study. (PPLB – 01). Indian Journal of Surgical Oncology 7:4, pages 397-406.
Crossref
Crossref
Hari SinghalMarianne E. Greene, Gerard TarulliAllison L. Zarnke, Ryan J. BourgoMuriel LaineYa-Fang ChangShihong MaAnna G. Dembo, Ganesh V. RajTheresa E. Hickey, Wayne D. TilleyGeoffrey L. Greene. (2016) Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. Science Advances 2:6.
Crossref
Crossref
Antonia Wenners, Felix Hartmann, Arne Jochens, Anna Maria Roemer, Ibrahim Alkatout, Wolfram Klapper, Marion van Mackelenbergh, Christoph Mundhenke, Walter Jonat & Maret Bauer. (2015) Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer. International Journal of Clinical Oncology 21:3, pages 548-556.
Crossref
Crossref
Cecilia J. Proietti, Franco Izzo, María Celeste Díaz Flaqué, Rosalía Cordo Russo, Leandro Venturutti, María Florencia Mercogliano, Mara De Martino, Viviana Pineda, Sergio Muñoz, Pablo Guzmán, Juan C. Roa, Roxana Schillaci & Patricia V. Elizalde. (2015) Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth. Molecular Endocrinology 29:10, pages 1468-1485.
Crossref
Crossref
Caroline H Diep, Andrea R Daniel, Laura J Mauro, Todd P Knutson & Carol A Lange. (2015) Progesterone action in breast, uterine, and ovarian cancers. Journal of Molecular Endocrinology 54:2, pages R31-R53.
Crossref
Crossref
A R Daniel, A L Gaviglio, T P Knutson, J H Ostrander, A B D'Assoro, P Ravindranathan, Y Peng, G V Raj, D Yee & C A Lange. (2014) Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene 34:4, pages 506-515.
Crossref
Crossref
Mani Roshan-Moniri, Michael Hsing, Miriam S. Butler, Artem Cherkasov & Paul S. Rennie. (2014) Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers. Cancer Treatment Reviews 40:10, pages 1137-1152.
Crossref
Crossref
Ana Gracanin, Fabiana A. Voorwald, Monique van Wolferen, Elpetra Timmermans-Sprang & Jan A. Mol. (2014) Marginal activity of progesterone receptor B (PR-B) in dogs but high incidence of mammary cancer. The Journal of Steroid Biochemistry and Molecular Biology 144, pages 492-499.
Crossref
Crossref
William H. Hudson, Christine Youn & Eric A. Ortlund. (2014) Crystal Structure of the Mineralocorticoid Receptor DNA Binding Domain in Complex with DNA. PLoS ONE 9:9, pages e107000.
Crossref
Crossref
S. Guil-Luna, J. Stenvang, N. Brünner, R. Sánchez-Céspedes, Y. Millán, J. Gómez-Laguna & J. Martín de las Mulas. (2013) Progesterone Receptor Isoform Analysis by Quantitative Real-Time Polymerase Chain Reaction in Formalin-Fixed, Paraffin-Embedded Canine Mammary Dysplasias and Tumors. Veterinary Pathology 51:5, pages 895-902.
Crossref
Crossref
Ling Gao, Michael M. Yue, Jennifer Davis, Elisabeth Hyjek & Lucia Schuger. (2014) In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor. Virchows Archiv 464:4, pages 495-503.
Crossref
Crossref
María C Díaz Flaqué, Natalia M Galigniana, Wendy Béguelin, Rocío Vicario, Cecilia J Proietti, Rosalía Cordo Russo, Martín A Rivas, Mercedes Tkach, Pablo Guzmán, Juan C Roa, Esteban Maronna, Viviana Pineda, Sergio Muñoz, María Florencia Mercogliano, Eduardo H Charreau, Patricio Yankilevich, Roxana Schillaci & Patricia V Elizalde. (2013) RETRACTED ARTICLE: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy. Breast Cancer Research 15:6.
Crossref
Crossref
Christy R. Hagan, Todd P. Knutson & Carol A. Lange. (2013) A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells. Nucleic Acids Research 41:19, pages 8926-8942.
Crossref
Crossref
EN-QI QIAO, MINGHUA JI, JIANZHONG WU, JIAN LI, XINYU XU, RONG MA, XIAOHUA ZHANG, YUEJUN HE, QUANBIN ZHA, XUE SONG, LIWEI ZHU & JI-HAI TANG. (2013) Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer. Molecular and Clinical Oncology 1:4, pages 703-710.
Crossref
Crossref
Rocio Sampayo, Sol Recouvreux & Marina Simian. 2013. Hormones and Breast Cancer. Hormones and Breast Cancer
185
201
.
Nadiyah Kazmi, Diana C Márquez-Garbán, Lilia Aivazyan, Nalo Hamilton, Edward B Garon, Lee Goodglick & Richard J Pietras. (2012) The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer. Lung Cancer Management 1:4, pages 259-272.
Crossref
Crossref
A Gracanin, J de Gier, K Zegers, M Bominaar, GR Rutteman, AC Schaefers‐Okkens, HS Kooistra & JA Mol. (2012) Progesterone Receptor Isoforms in the Mammary Gland of Cats and Dogs. Reproduction in Domestic Animals 47:s6, pages 313-317.
Crossref
Crossref
Todd P Knutson, Andrea R Daniel, Danhua Fan, Kevin AT Silverstein, Kyle R Covington, Suzanne AW Fuqua & Carol A Lange. (2012) Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression. Breast Cancer Research 14:3.
Crossref
Crossref
Xiuli Wang & David L. Kaplan. (2012) Hormone-responsive 3D multicellular culture model of human breast tissue. Biomaterials 33:12, pages 3411-3420.
Crossref
Crossref